CXCL8 and breast carcinoma: Although this still needs further investigation, exploratory analysis from a randomized controlled trial showed that having increased inflammatory markers of interleukin (IL)-8 and Tumor Necrosis Factor-alpha (TNF-α) at diagnosis was associated with an RDI < 85% in patients with breast cancer [38].